Friday, June 03, 2011
Summary measures of quality of care and States' performances relative to all States and the region by:
Overall health care quality
Types of care (preventive, acute, and chronic)
Settings of care (hospitals, ambulatory care, nursing home, and home health)
Five clinical conditions (cancer, diabetes, heart disease, maternal and child health, and respiratory diseases)
Special focus areas on diabetes, asthma, Healthy People 2010, clinical preventive services, disparities, payer, and variation over time
Cancer's Last Stand? The Genome Solution - Wielding Genomes in the Fight Against Cancer - NYTimes.com
"The researchers agreed that there should be global clinical trials of new cancer drugs, and that all patients should have genetic information about their tumors entered into databases that researchers everywhere could study. Dr. Lander said that concerns about genetic privacy had been “fetishized,” and that the potential harm to patients from releasing their genetic information paled next to the harm threatened by their disease."
FYI - (wiki) Terry Fox legacy - Marathon of Hope
press release: EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients Phase 2 Data Presented in ASCO Poster Discussion Session
phase 2 study with ENMD-2076 in platinum-resistant ovarian cancer patients
Does it run in the family? Toolkit will soon be available at federal health centers nationwide, Genetic Alliance, June 2
New Blog Post (click on image below)
What is Public Health Genomics? A Day in the Invisible Life of Public Health Genomics.
Find EXACT phrase: lmp ovarian
Found 1 document.
A multivariate longitudinal algorithm for early detection of ovarian cancer using multiple biomarker
Find EXACT phrase: borderline ovarian
Found 2 documents, showing 1 - 2
- Regulation of the tumor suppressor gene PAEP in the transition from serous borderline ovarian tumors to low-grade serous ovarian carcinomas. | 2011 ASCO Annual Meeting Abstracts
... from serous borderline ovarian tumors to low-grade serous ovarian carcinomas. | 2011 ASCO ...
... Background: Serous borderline ovarian tumors (SBOT) and low grade serous ovarian carcinomas (LG) ...
of HE4 and CA 125 in symptomatic patients with invasive epithelial
ovarian cancer. | 2011 ASCO Annual Meeting Abstracts
... were malignant. Borderline ovarian tumors were excluded from the analyses. A total of 115 cases ...
No documents found relating to your query/s.
Find EXACT phrase: gynecologic oncologist
Find EXACT phrase: gynaecologic oncologist
Mutational analysis and clinical correlation of 185 consecutive metastatic colorectal patients: Similarities and differences between colon and rectal patients| 2011 ASCO Abstract
Rectal and colon patients have similar rates of KRAS and PIK3CA mutations. However, BRAF mutations are more common in colon cancer. NRAS mutations are exclusively found in rectosigmoid cancers and may have a different biology than other colorectal cancers. These data suggest that primary tumor location may provide a means to enrich a population for a genotype-directed study.